Internal Medicine, Endocrinology, Diabetes, & Metabolism · Knoxville, TN
NPI
1316997398
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
9303 Park West Blvd Ste 100
Knoxville, TN, 37923
Phone (865) 951-0083
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
8,697 services
Medicare patients, 2024
365
Average age 70
Drug cost, 2024
$6.8M
13,111 prescriptions
Company payments, 2025
$4,055
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mubashir Mahmood was code 85025 (blood count), 240 times for 145 patients. In total Mubashir Mahmood billed 8,697 services in 104 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 240 | 145 | $7.61 | $1,826 |
| 80053 Clinical Chemistry | Office | 238 | 143 | $10.35 | $2,463 |
| 81003 Clinical Chemistry | Office | 228 | 138 | $2.14 | $488 |
| 83036 Blood Count | Office | 209 | 141 | $9.41 | $1,966 |
| 84443 Clinical Chemistry | Office | 194 | 120 | $16.46 | $3,193 |
| 82306 Clinical Chemistry | Office | 191 | 129 | $28.48 | $5,440 |
| 84439 Clinical Chemistry | Office | 189 | 113 | $8.73 | $1,650 |
| 77080 Standard X-ray | Office | 167 | 167 | $10.73 | $1,792 |
| 84481 Clinical Chemistry | Office | 157 | 104 | $16.35 | $2,567 |
| 80061 Clinical Chemistry | Office | 141 | 115 | $12.59 | $1,776 |
| 82728 Clinical Chemistry | Office | 139 | 93 | $13.13 | $1,826 |
| 82962 Clinical Chemistry | Office | 136 | 86 | $3.09 | $421 |
| 99215 Office E&M - Established | Office | 132 | 102 | $128.23 | $17K |
| 82607 Clinical Chemistry | Office | 125 | 87 | $14.60 | $1,825 |
| 99214 Office E&M - Established | Office | 116 | 79 | $76.79 | $8,908 |
By year: 2022 $70K for 6,135 services; 2023 $76K for 10,199 services; 2024 $85K for 8,697 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 240 | 145 | $7.61 | $1,826 |
| 80053 Clinical Chemistry | 238 | 143 | $10.35 | $2,463 |
| 81003 Clinical Chemistry | 228 | 138 | $2.14 | $488 |
| 83036 Blood Count | 209 | 141 | $9.41 | $1,966 |
| 84443 Clinical Chemistry | 194 | 120 | $16.46 | $3,193 |
| 82306 Clinical Chemistry | 191 | 129 | $28.48 | $5,440 |
| 84439 Clinical Chemistry | 189 | 113 | $8.73 | $1,650 |
| 84481 Clinical Chemistry | 157 | 104 | $16.35 | $2,567 |
| 80061 Clinical Chemistry | 141 | 115 | $12.59 | $1,776 |
| 82728 Clinical Chemistry | 139 | 93 | $13.13 | $1,826 |
Medicare prescription drug claims, 2024
In 2024, the drug Mubashir Mahmood prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,249 prescriptions and refills. In total Mubashir Mahmood wrote 13,111 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,249 | 3,153 | 495 | $9,379 |
| Metformin Hcl Er Metformin Hcl | 802 | 2,048 | 354 | $6,228 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 711 | 1,922 | 362 | $17K |
| Fluconazole Generic | 697 | 715 | 294 | $9,783 |
| Ozempic Semaglutide | 518 | 955 | 200 | $933K |
| Jardiance Empagliflozin | 510 | 1,082 | 234 | $652K |
| Liothyronine Sodium Generic | 435 | 1,100 | 170 | $14K |
| Farxiga Dapagliflozin Propanediol | 369 | 739 | 151 | $424K |
| Mounjaro Tirzepatide | 341 | 490 | 121 | $540K |
| Glimepiride Generic | 301 | 773 | 147 | $2,227 |
| Rosuvastatin Calcium Generic | 260 | 705 | 112 | $2,919 |
| Fluticasone Propionate Generic | 246 | 359 | 114 | $3,828 |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 240 | 441 | 130 | $119K |
| Colestipol Hcl Generic | 235 | 415 | 112 | $36K |
| Ropinirole Hcl Generic | 224 | 567 | 92 | $4,206 |
Brand drugs: 4,375 claims; generic drugs: 7,837 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mubashir Mahmood $4,055 ($4,055 in general payments such as food, travel and fees) from 31 companies. The largest payer was Lilly USA, LLC with $459.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 32 | $459 |
| Amgen Inc. AMGN | 20 | $361 |
| Dexcom, Inc. DXCM | 18 | $350 |
| Insulet Corporation PODD | 20 | $303 |
| Novo Nordisk Inc NVO | 16 | $287 |
| Xeris Pharmaceuticals, Inc. | 17 | $272 |
| Abbott Laboratories ABT | 20 | $258 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 14 | $215 |
| Corcept Therapeutics CORT | 15 | $206 |
| Medtronic, Inc. MDT | 18 | $186 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.